New treatment options in mantle cell lymphoma

  • W. Hiddemann


Mantle cell lymphoma has only recently been generally accepted as a distinct lymphoma entity. Hence, available clinical information is hampered by the lack of a uniformly accepted pathologic classification [11.1]. Furthermore, all series published so far are small, and mostly based on retrospective evaluations.


Follicular Lymphoma Mantle Cell Lymphoma Alpha Interferon Bone Marrow Involvement Autologous Hematopoietic Stem Cell Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brittinger G, Bartels H, Common H et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984; 2:269–306.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood 1995; 85:1075–82.PubMedGoogle Scholar
  3. 3.
    Wagner R, Press OW. Educational Booklet. Am Soc Hematol 1995:36–44.Google Scholar
  4. 4.
    Berger F, Felman P, Sonet A et al. Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. Blood 1994; 83: 2829–35.PubMedGoogle Scholar
  5. 5.
    Zucca E, Fontana S, Roggero E, Pedrinis E, Pampallona S, Cavalli F. Treatment and prognosis of centrocytic (mantle cell) lymphoma: a retrospective analysis of twenty-six patients treated in one institution. Leuk Lymphoma 1994; 13:105–10.PubMedCrossRefGoogle Scholar
  6. 6.
    Weisenburger DD, Nathwani BN, Diamond LW, Winberg CD, Rappaport H. Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer 1981; 48: 1415–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Meusers P, Engelhard M, Bartels H et al. Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol 1989; 7: 365–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Norton AJ, Matthews J, Pappa V et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol 1995; 6: 249–56.PubMedGoogle Scholar
  9. 9.
    Pittaluga S, Wlodarska I, Stul MS et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 1995; 26: 17–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Stewart DA, Vose JM, Weisenburger DD et al. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 1995; 6: 263–6.PubMedGoogle Scholar
  11. 11.
    Zucca E, Roggero E, Pinotti G et al. Patterns of survival in mantle cell lymphoma. Ann Oncol 1995; 6: 257–62.PubMedGoogle Scholar
  12. 12.
    Narang S, Wolf BC, Neiman RS. Malignant lymphoma presenting with prominent splenomegaly. A clinicopathologic study with special reference to intermediate cell lymphoma. Cancer 1985; 55: 1948–57.PubMedCrossRefGoogle Scholar
  13. 13.
    Duggan MJ, Weisenburger DD, Ye YL et al. Mantle zone lymphoma. A clinicopathologic study of 22 cases. Cancer 1990; 66:522–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Meusers P, Engelhard M, Bartels H et al. Mantle cell (centrocytic) lymphoma: long-term survival with advanced disease is possible. Blood 1996; 86 (Suppl 1): 53a.Google Scholar
  15. 15.
    Teodorovic I, Pittaluga S, Kluin-Nelemans JC et al. Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non Hodgkin’s lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1995; 13: 2819–26.PubMedGoogle Scholar
  16. 16.
    Haas R, Brittinger G, Meusers P et al. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma. Leukemia 1996; 10:1975–9.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 1999

Authors and Affiliations

  • W. Hiddemann

There are no affiliations available

Personalised recommendations